Pine Haven Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Pine Haven Investment Counsel's AMGN Position: Q2 2026 in Review
Pine Haven Investment Counsel reduced its Amgen (AMGN) stake by 0.36% in Q2 2026, selling an estimated $7.87K and leaving 6,341 shares worth $2.3M. The position accounts for 1.54% of the portfolio, ranked #14.
Pine Haven Investment Counsel first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Pine Haven Investment Counsel held 6,341 shares of Amgen worth $2.3M as of Q2 2026.
- Pine Haven Investment Counsel sold 23 Amgen shares in Q2 2026, an estimated $7.87K.
- Amgen made up 1.54% of Pine Haven Investment Counsel's portfolio in Q2 2026, its #14 holding.
- Pine Haven Investment Counsel first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Pine Haven Investment Counsel's 13F filing for Q2 2026, filed 8 Jul 2026.